PPARγ and inflammatory bowel disease: A new therapeutic target for ulcerative colitis and Crohn's disease

Trends in Molecular Medicine

Volumn 7, Issue 8, 2001, Pages 329-331

  Wada, Koichiro ^a   Nakajima, Atsushi ^b   Blumberg, Richard S ^c  

^a OSAKA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; TRINITROBENZENESULFONIC ACID; TROGLITAZONE; TUMOR NECROSIS FACTOR ANTIBODY; ANTIINFLAMMATORY AGENT; CELL RECEPTOR; CHROMAN DERIVATIVE; LIGAND; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DRUG MECHANISM; ENTEROPATHY; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; ULCERATIVE COLITIS; ANIMAL; DISEASE MODEL; GENETICS; INTESTINE; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHROMANS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; INFLAMMATION; INTESTINES; LIGANDS; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0034742533     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02076-7     Document Type: Short Survey

References (27)

1. Low-dose cyclosporine for the treatment of Crohn's disease
2. Prospects for research in inflammatory bowel disease
3. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
4. Attenuation of colon inflammation through activators of retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (PPARγ) heterodimer: A basis for new therapeutic strategies
5. Adipogenesis and obesity: Rounding out the big picture
6. PPARγ mediated high-fat diet-induced adipocyte hypertrophy and insulin resistance
7. Medical significance of peroxisome proliferator-activated receptors
8. Roles of PPARs in health and disease
9. Differential expression of peroxisome proliferator activated receptor-α, -β, and -γ during rat embryonic development
10. Activators of the nuclear receptor PPARγ enhance colon polyp formation
11. Peroxisome proliferator-activated receptors: Tree isotypes for a multitude of functions
12. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC Min/+mice
13. Differentiation and reversal of malignant changes in colon can ce c through PPARγ
14. PPAR gamma and colorectal carcinoma: Conflicts in a nuclear family
15. A novel therapy for colitis utilizing PPARγ ligands to inhibit the epithelial inflammatory response
16. Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
17. Ulcerative colitis is associated with a mucosal deficit in PPARγ
18. PPARγ dependent and independent effects on macrophages gene expression in lipid metabolism and inflammation
19. The role of PPARγ in macrophage differentiation and cholesterol uptake
20. Nuclear factor-κB: Apivotal transcription factor in chronic inflammatory diseases
21. Multiple signals covering on NF-κB
22. Phosphorylation meets ubiquitination: The control of NF-κB activity
23. JNK or IKK, AP-or NF-κB, which are the targets for MEK kinase 1 action?
24. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IκB phosphorylation and NF-κB activation
25. Tumor necrosis factor: Biology and therapeutic inhibitors
26. Biology of inflammation in Crohn's disease: Mechanisms of action of anti-TNFα therapy
27. Treatment of ulcerative colitis (UC) with PPARγ ligands: Preliminary results ora pilot study